November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Michael Ong received $2.4M for metastatic prostate cancer – CCTG
Aug 12, 2024, 01:27

Michael Ong received $2.4M for metastatic prostate cancer – CCTG

The Canadian Cancer Trials Group shared on X:

Congratulations to Dr Michael Ong, who has received $2,487,015 over 7 years from CIHR to support the CCTG PR26 (TRIPLE-SWITCH) trial. The study aims to personalize chemotherapy use and improve survival for patients with metastatic prostate cancer.

Read further.
Source: The Canadian Cancer Trials Group/X